Newport Beach, CA6 Active Studies

Pulmonary Hypertension Clinical Trials in Newport Beach, CA

Find 6 actively recruiting pulmonary hypertension clinical trials in Newport Beach, CA. Connect with local research sites and explore new treatment options.

6
Active Trials
6
Sponsors
2,853
Enrolling

Recruiting Pulmonary Hypertension Studies in Newport Beach

About Pulmonary Hypertension Clinical Trials in Newport Beach

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 6 pulmonary hypertension clinical trials recruiting participants in Newport Beach, CA. These studies are seeking a combined 2,853 participants. Research is being sponsored by Stratpharma AG, AstraZeneca, SWOG Cancer Research Network and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Newport Beach — FAQ

Are there pulmonary hypertension clinical trials in Newport Beach?

Yes, there are 6 pulmonary hypertension clinical trials currently recruiting in Newport Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 6 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 18, 2026 from ClinicalTrials.gov